TE Tirzepatide Editorial

Governance

Medical and Pharmacy Reviewer Directory

Released: · Last reviewed:

Direct answer

Reviewers on this site are named, and their National Provider Identifiers are verified against the public CMS NPPES registry. Every page is medically reviewed by both: Dr. Jonathan Snipes, MD, who leads on medical, dosing, safety and research content, and Kim Callender, NP (FNP-BC), who leads on provider, cost and pharmacy content. Pages are researched and drafted by Dr. Parmis, Medical Researcher — a separate role for which no clinical-review authority is asserted.

Key takeaways

  • Two medical reviewers hold verified NPI records checked against the CMS NPPES registry.
  • Both reviewers review every page; each has a published area of emphasis.
  • Research and drafting is a distinct role, held by Dr. Parmis, for which no clinical-review authority is asserted.
  • Clinical review confirms language accuracy and creates no clinician-patient relationship.
  • Every reviewed page displays a separate medically reviewed date.
Key facts
Clinical reviewers2, both with NPI verified in CMS NPPES
Research role1 — Dr. Parmis, Medical Researcher (no clinical-review authority asserted)
Verification methodNPI checked against the public CMS NPPES registry
Review coverageBoth reviewers review every page; emphasis: medical/dosing/safety/research (Dr. Snipes) and provider/cost/pharmacy (Kim Callender)
DisplayedResearcher, both reviewers and the review date on every page
Verified
Medical reviewers Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Released 2026-07-22
Updated
Methodology v4.1

Who reviews clinical content?

Who researches and drafts pages?

Pages are researched and drafted by Dr. Parmis Mojarab, credited in bylines as “Dr. Parmis”, Medical Researcher, Western University of Health Sciences. The role is distinct from medical review: no clinical-review authority is asserted for it, and every page she researches is medically reviewed by both reviewers above.

What does NPI verification actually prove?

That the individual holds a National Provider Identifier registered in the public CMS database with the stated name and credential. It confirms the person is a real, identifiable clinician rather than an invented byline. It does not by itself confirm specialty board certification or licensure status in a given state, which are separate records.

Why this page exists. Anonymous or vaguely-credentialled review is common in health publishing. Naming reviewers with checkable identifiers is what makes the review claim falsifiable.

How much of this site's data is actually verified?

Trials with full identifiers8Trials partially verified1Trials withheld pending audit1Providers with a standing all-in price15Providers listed with a reason28$/month
The published state of every dataset behind this site. Of 43 provider records in the November 8, 2026 index, 15 publish a standing all-in price; the other 28 are listed with the reason (18 print a figure that is not like-for-like, 10 have no comparable price) rather than being quietly estimated.
Data for: Verification state of the published datasets
GroupRecords
Trials with full identifiers8
Trials partially verified1
Trials withheld pending audit1
Providers with a standing all-in price15
Providers listed with a reason28
Evidence statuses applied across every page and dataset
Evidence statusDefinitionWhat may be published
VerifiedChecked against a primary source with a recorded dateThe claim, with its identifier and date
Partially verifiedSome elements confirmed, others outstandingConfirmed elements only; the rest labelled
Verification PendingNot yet checked against a primary sourceNo factual assertion — the gap is shown

What does this page cover, and what does it deliberately leave out?

This page addresses Credentials, licenses, specialties and review scopes and conflicts, organised around the primary question of tirzepatide medical reviewers. Each of those elements is treated separately below rather than blended, because they carry different evidence weights and a reader is entitled to know which parts rest on randomised data and which rest on a captured commercial claim or a regulatory document.

Scope of this page and the basis for each element
ElementTreatment hereEvidence basis
CredentialsCovered on this pageRegulatory or policy source
LicensesCovered on this pageRegulatory or policy source
SpecialtiesCovered on this pageRegulatory or policy source
Review scopes and conflictsCovered on this pageRegulatory or policy source
Individualized clinical instructionDeliberately not coveredBelongs with the corrections process

What are the limits of what this page can tell you?

Every page on this site rests on a specific published policy, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.

Specific limitations.
  • The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for the corrections process.
  • Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
  • Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
  • Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.

What would change the conclusion on this page?

Any of the following would change what this page concludes:

  • New primary evidence bearing directly on tirzepatide medical reviewers.
  • A change to FDA labelling affecting any statement made above.
  • A verified correction submitted through the corrections process and accepted on the evidence.
  • A material change to a captured record, including a price, term, or regulatory status.
  • Completion of a verification currently marked pending, which would replace a gap with a stated fact.

Frequently asked questions

Who reviews content on this site?

Both named medical reviewers — Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC) — review every page; their NPI records are verified in the CMS NPPES registry.

What does NPI verification confirm?

That the reviewer is a real, identifiable clinician registered in the public CMS database. It does not by itself confirm board certification or state licensure.

Is the medical researcher a medical reviewer?

No. Dr. Parmis researches and drafts pages; no clinical-review authority is asserted for that role, and medical review is done by the two reviewers.

Does review make this medical advice?

No. Review checks published language and creates no clinician-patient relationship.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Change history

Substantive changes to this page
DateChange
2026-07-22Page published with current dataset snapshot.
2026-09-04Shared cost components and disclosures rebuilt from the 2026-09-04 dataset (NexLife September 2026 card re-read live; Yucca Health and a program since removed from this site added; NexLife disclosed as a commercial partner, labelled where it appears).
2026-11-08Directory updated: both reviewers review every page (areas of emphasis kept); the editorial-governance role (Editorial Auditor) replaced by Dr. Parmis's role as Medical Researcher, Western University of Health Sciences, who researches and drafts pages. Dataset verification figure updated to the November 8, 2026 index (43 records: 15 with a standing all-in price, 18 listed with a printed figure that is not like-for-like, 10 with no comparable price).

Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.

What else is in this section?